tiprankstipranks
Trending News
More News >
Akari Therapeutics (AKTX)
NASDAQ:AKTX
US Market

Akari Therapeutics (AKTX) Income Statement

Compare
284 Followers

Akari Therapeutics Income Statement

Last quarter (Q1 2025), Akari Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Akari Therapeutics's net income was $-3.71M. See Akari Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00----
Operating Expenses
$ 21.64M$ 16.81M$ 23.89M$ 17.21M$ 20.10M
Depreciation and Amortization
$ -1.61M$ 4.00K---
EBITDA
$ -21.64M$ -16.80M$ -23.08M$ -17.21M$ -20.44M
Operating Income
$ -21.64M$ -16.81M$ -23.09M$ -17.21M$ -17.98M
Other Income/Expenses
$ 1.85M$ 6.80M$ 5.34M$ -210.10K$ 899.36K
Pretax Income
$ -19.79M$ -10.01M$ -17.75M$ -17.42M$ -20.45M
Net Income
$ -19.79M$ -10.01M$ -6.97M$ -17.61M$ -17.60M
Per Share Metrics
Basic EPS
$ -1.60$ 0.00$ 0.00$ 0.00$ -0.01
Diluted EPS
$ -1.60$ 0.00$ 0.00$ 0.00$ -0.01
Weighted Average Shares Outstanding
11.94M 9.79B 6.24B 4.29B 2.25B
Weighted Average Shares Outstanding (Diluted)
11.94M 9.79B 6.24B 4.29B 3.16B
Currency in USD

Akari Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis